Literature DB >> 23174407

High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics.

Ayumu Hirata1, Ken Kishida, Hideaki Nakatsuji, Hironori Kobayashi, Tohru Funahashi, Iichiro Shimomura.   

Abstract

OBJECTIVE: Adiponectin, an adipocyte-derived protein, has potential antiatherogenic properties. Low levels of serum total-adiponectin (Total-APN) correlate with diabetes and coronary artery disease (CAD). Adiponectin and C1q form a protein complex in blood, and serum C1q-binding adiponectin (C1q-APN) can be measured. We investigated the correlation between C1q-APN and CAD in patients with type 2 diabetes mellitus (T2DM).
METHODS: The study subjects were 107 outpatients with T2DM who underwent evaluation for CAD. Blood C1q, Total-APN, high-molecular weight-adiponectin (HMW-APN) and C1q-APN were measured by enzyme-linked immunosorbent assays.
RESULTS: Serum levels of C1q-APN/Total-APN ratio were higher in patients diagnosed with CAD (10.47±0.59, mean±SEM, n=54) than those without CAD (8.88±0.60, n=53, p=0.0482). Age- and sex-adjusted logistic regression analysis identified serum C1q-APN/Total-APN ratio and hypertension as significant and independent determinants of CAD. A high serum C1q-APN/Total-APN ratio was associated with 3.965-fold increase in CAD prevalence.
CONCLUSIONS: High serum C1q-APN/Total-APN ratio correlates with CAD in T2DM.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174407     DOI: 10.1016/j.metabol.2012.10.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus.

Authors:  Su-Jin Kim; Sehyun Chae; Hokeun Kim; Dong-Gi Mun; Seunghoon Back; Hye Yeon Choi; Kyong Soo Park; Daehee Hwang; Sung Hee Choi; Sang-Won Lee
Journal:  Mol Cell Proteomics       Date:  2014-01-08       Impact factor: 5.911

2.  High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome.

Authors:  Ken Kishida; Yasuhiko Nakagawa; Hironori Kobayashi; Toru Mazaki; Hiroyoshi Yokoi; Koji Yanagi; Tohru Funahashi; Iichiro Shimomura
Journal:  Cardiovasc Diabetol       Date:  2014-01-09       Impact factor: 9.951

3.  Westernization of lifestyle affects quantitative and qualitative changes in adiponectin.

Authors:  Mitsunobu Kubota; Masayasu Yoneda; Norikazu Maeda; Haruya Ohno; Kenji Oki; Tohru Funahashi; Iichiro Shimomura; Noboru Hattori
Journal:  Cardiovasc Diabetol       Date:  2017-07-06       Impact factor: 9.951

4.  Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report.

Authors:  Hideaki Nakatsuji; Ken Kishida; Hironori Kobayashi; Tohru Nakagawa; Tohru Funahashi; Iichiro Shimomura
Journal:  Diabetol Metab Syndr       Date:  2013-03-27       Impact factor: 3.320

5.  Serum C1q- binding adiponectin in maintenance hemodialysis patients.

Authors:  Ken Kishida; Naohiro Kishida; Masaaki Arima; Hideaki Nakatsuji; Hironori Kobayashi; Tohru Funahashi; Iichiro Shimomura
Journal:  BMC Nephrol       Date:  2013-02-26       Impact factor: 2.388

6.  The amount of C1q-adiponectin complex is higher in the serum and the complex localizes to perivascular areas of fat tissues and the intimal-medial layer of blood vessels of coronary artery disease patients.

Authors:  Eun Shil Hong; Cheong Lim; Hye Yeon Choi; Eu Jeong Ku; Kyoung Min Kim; Jae Hoon Moon; Soo Lim; Kyong Soo Park; Hak Chul Jang; Sung Hee Choi
Journal:  Cardiovasc Diabetol       Date:  2015-05-09       Impact factor: 9.951

7.  The effect of chromium picolinate supplementation on the pancreas and macroangiopathy in type II diabetes mellitus rats.

Authors:  Shan Huang; Wenfang Peng; Xiaohong Jiang; Kan Shao; Lili Xia; Yubin Tang; Jiayin Qiu
Journal:  J Diabetes Res       Date:  2014-06-25       Impact factor: 4.011

8.  Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.

Authors:  Ken Kishida; Yasuhiko Nakagawa; Hironori Kobayashi; Koji Yanagi; Tohru Funahashi; Iichiro Shimomura
Journal:  Diabetol Metab Syndr       Date:  2014-05-27       Impact factor: 3.320

Review 9.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.